Different methods, different results--how do available methods link a patient's anticholinergic load with adverse
Tanja Mayer1,2, Walter E Haefeli1,2, Hanna M Seidling3,4
1Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
Anticholinergic drug burden varies significantly across calculation methods, impacting patient outcomes. Standardizing anticholinergic load assessment is crucial for accurate comparisons and improved patient care.
Area of Science:
- Geriatric Pharmacology
- Drug Safety and Pharmacoepidemiology
Background:
- Anticholinergic drugs can cause significant physical and cognitive impairment, especially in elderly patients.
- Anticholinergic load quantifies cumulative exposure to these medications.
- Existing methods for calculating anticholinergic load lack standardization.
Purpose of the Study:
- To review and compare different methods for calculating anticholinergic load.
- To identify discrepancies in the development and evaluation of these calculation methods.
Main Methods:
- Systematic literature search using PRISMA guidelines (PubMed, Sept 2014 - Aug 2015).
- Identified studies calculating anticholinergic load using scales or equations.
- Descriptively analyzed identification criteria, scoring, and outcome assessment methods.
Main Results:
- 55 studies using 12 scales and 1 equation were included.
- Significant discrepancies noted in drug identification criteria (8 types), scoring principles (2 types), and outcome measures (118 types).
- Effective methods incorporated drug dosage and potency; patient susceptibility and drug exposure modulators were rarely considered.
Conclusions:
- Varying outcome assessment methods limit comparability of current anticholinergic load calculations.
- Recommends calculating anticholinergic load using all available scales and equations for better outcome correlation.
More Related Videos
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
06:25Paw-Print Analysis of Contrast-Enhanced Recordings PrAnCER: A Low-Cost, Open-Access Automated Gait Analysis System for Assessing Motor Deficits
Published on: August 12, 2019
Related Concept Videos
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Cholinergic Antagonists: Pharmacokinetics
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
